[1] Key warnings include risks of pancreatitis, gallbladder disease, increased heart rate, dehydration leading to renal impairment, and suicidal ideation
Reddys Laboratories (DRL) and OneSource Specialty Pharma Ltd (OSSPL) from selling semaglutide domestically in a patent infringement suit filed by Novo Nordisk, a Danish drug manufacturer (pdf)
During menopause, the decline in estrogen levels removes a key layer of cardiovascular protection
To get approved, your client must meet one of the following criteria: BMI of 35 or higher: Automatically qualifies for weight-loss coverage without needing a secondary health condition
Zij zijn niet bestemd voor medische toepassingen, diagnose, behandeling of genezing
Overall, the conversation around the drugs risks reversing progress on the idea that there can be health at every size, Richmond said